Risk Factors for Post Whipple Pancreatic Fistula
Sponsor
Assiut University (Other)
Overall Status
Completed
CT.gov ID
NCT05014425
Collaborator
(none)
96
48
Study Details
Study Description
Brief Summary
Postoperative pancreatic fistula (POPF) following pancreaticoduodenectomy is considered a life-threatening complication. This study was designed to analyze the risk factors for development of such fistula in a tertiary care center (Al-Rajhi Liver Hospital/ Assiut University).
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
96 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Risk Factors Predicting Development of Pancreatic Fistula Following Pancreaticoduodenectomy
Actual Study Start Date
:
Jan 1, 2017
Actual Primary Completion Date
:
Dec 31, 2020
Actual Study Completion Date
:
Dec 31, 2020
Outcome Measures
Primary Outcome Measures
- Development of pancreatic fistula following pancreaticoduodenectomy [Baseline]
Analysis of risk factors for development of pancreatic fistula following pancreaticoduodenectomy
Eligibility Criteria
Criteria
Ages Eligible for Study:
N/A
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- All patients underwent pancreaticoduodenectomy for pancreatic cancer
Exclusion Criteria:
- All types of pancreatic resection other than pancreaticoduodenectomy
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Assiut University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Ramy A. Hassan,
Dr.,
Assiut University
ClinicalTrials.gov Identifier:
NCT05014425
Other Study ID Numbers:
- Pancreatic fistula
First Posted:
Aug 20, 2021
Last Update Posted:
Aug 20, 2021
Last Verified:
Aug 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: